Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?

Paesmans Marianne

Source: Eur Respir J 2015; 46: 1259-1261
Journal Issue: November

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paesmans Marianne. Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?. Eur Respir J 2015; 46: 1259-1261

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?
Source: Eur Respir J 2014; 43: 1240-1242
Year: 2014


Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008



Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease
Source: Eur Respir J 2014; 43: 1439-1447
Year: 2014



An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

The comparison of clinical and pathological stages of the non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 89s
Year: 2006

Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Time lost for diagnostics of lung carcinoma related to disease stage and prognosis
Source: Eur Respir J 2004; 24: Suppl. 48, 297s
Year: 2004

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


The clinical value of autoflurescence bronchoscopy for precancerous lesions in operable primary lung cancer patients
Source: Annual Congress 2007 - Diagnostic bronchoscopy and transthoracic aspiration
Year: 2007


Surgically resected bronchioloalveolar carcinoma – T-status, N-status, pTNM stage and survival
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006

Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005

Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006

Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression
Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Year: 2006


Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012